ID   84BR
AC   CVCL_2293
SY   84 BRighton
DR   CLO; CLO_0001512
DR   CLDB; cl134
DR   ECACC; 90011805
DR   Wikidata; Q54605339
RX   PubMed=8609460;
RX   PubMed=23093295;
CC   Doubling time: 48 hours (PubMed=8609460).
CC   Donor information: Established from the non-affected skin biopsy of a radiosensitive breast cancer patient.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ECACC=90011805
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 8,13
ST   D16S539: 11,12
ST   D5S818: 11,14
ST   D7S820: 9,10
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
RX   PubMed=8609460; DOI=10.1080/095530096146075;
RA   Alsbeih G.A., Fertil B., Arlett C.F., Malaise E.-P.;
RT   "High split-dose recovery in hypersensitive human fibroblasts: a case
RT   of induced radioresistance?";
RL   Int. J. Radiat. Biol. 69:225-239(1996).
//
RX   PubMed=23093295; DOI=10.1038/bjc.2012.443; PMCID=PMC3493778;
RA   Senguloglu G.U., Arlett C.F., Plowman P.N., Parnell J., Patel N.,
RA   Bourton E.C., Parris C.N.;
RT   "Elevated expression of artemis in human fibroblast cells is
RT   associated with cellular radiosensitivity and increased apoptosis.";
RL   Br. J. Cancer 107:1506-1513(2012).
//